Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Szu-Chun Yang

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
ERJ Open Research|March 6, 2024
Possible overdiagnosis of early-stage lung adenocarcinoma among never-smokers in TaiwanSzu-Chun Yang, Wu-Wei Lai, Tzu-I Wu, et al.
Therapeutic Advances in Medical Oncology|January 6, 2025
Cost-effectiveness of lazertinib as first-line treatment in patients with <i>EGFR</i>-mutated advanced lung cancerLi-Jung Elizabeth Ku, Jui-Hung Tsai, Li-Jun Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 19, 2024
Effective prevention in clinical practice may save human capital loss: Real-world evidence from Taiwan's National Health InsuranceFuhmei Wang, Wen-Yen Huang, Yu-Tzu Chang, et al.
Scientific Reports|August 16, 2023
Estimation of disability free life expectancy in non small cell lung cancer based on real world dataShin-Mao Lin, Szu-Chun Yang, Tzu-I Wu, et al.
BMC Pulmonary Medicine|March 15, 2022
Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort studyChin-Wei Kuo, Szu-Chun Yang, Yu-Fen Shih, et al.
Plos One|April 9, 2020
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in TaiwanSzu-Chun Yang, Wu-Wei Lai, Jason C Hsu, et al.
Respirology (Carlton, Vic.)|June 24, 2022
PM<sub>2.5</sub> exposure and risk of lung adenocarcinoma in women of Taiwan: A case-control study with density samplingSzu-Chun Yang, Fang-Yu Lin, Tzu-I Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 21, 2024
Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocationJung-Der Wang, Wu-Wei Lai, Szu-Chun Yang, et al.
Journal of Health Psychology|September 10, 2015
Rasch models suggested the satisfactory psychometric properties of the World Health Organization Quality of Life-Brief among lung cancer patientsChung-Ying Lin, Szu-Chun Yang, Wu-Wei Lai, et al.
Frontiers in Oncology|December 27, 2021
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung CancerSzu-Chun Yang, Natalia Kunst, Cary P Gross, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
ERJ Open Research|March 6, 2024
Possible overdiagnosis of early-stage lung adenocarcinoma among never-smokers in TaiwanSzu-Chun Yang, Wu-Wei Lai, Tzu-I Wu, et al.
Therapeutic Advances in Medical Oncology|January 6, 2025
Cost-effectiveness of lazertinib as first-line treatment in patients with <i>EGFR</i>-mutated advanced lung cancerLi-Jung Elizabeth Ku, Jui-Hung Tsai, Li-Jun Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 19, 2024
Effective prevention in clinical practice may save human capital loss: Real-world evidence from Taiwan's National Health InsuranceFuhmei Wang, Wen-Yen Huang, Yu-Tzu Chang, et al.
Scientific Reports|August 16, 2023
Estimation of disability free life expectancy in non small cell lung cancer based on real world dataShin-Mao Lin, Szu-Chun Yang, Tzu-I Wu, et al.
BMC Pulmonary Medicine|March 15, 2022
Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort studyChin-Wei Kuo, Szu-Chun Yang, Yu-Fen Shih, et al.
Plos One|April 9, 2020
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in TaiwanSzu-Chun Yang, Wu-Wei Lai, Jason C Hsu, et al.
Respirology (Carlton, Vic.)|June 24, 2022
PM<sub>2.5</sub> exposure and risk of lung adenocarcinoma in women of Taiwan: A case-control study with density samplingSzu-Chun Yang, Fang-Yu Lin, Tzu-I Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 21, 2024
Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocationJung-Der Wang, Wu-Wei Lai, Szu-Chun Yang, et al.
Journal of Health Psychology|September 10, 2015
Rasch models suggested the satisfactory psychometric properties of the World Health Organization Quality of Life-Brief among lung cancer patientsChung-Ying Lin, Szu-Chun Yang, Wu-Wei Lai, et al.
Frontiers in Oncology|December 27, 2021
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung CancerSzu-Chun Yang, Natalia Kunst, Cary P Gross, et al.
Pageof 6